Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

NVO

Novo Nordisk ADR

Nov 25 • 04:00PM ET

47.06

+2.09 4.65 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PVAL PPH AVDE WCMI PID RVER APIE DFIC DIVZ OZEM

Scroll to Statements

Index	-	P/E	13.71	EPS (ttm)	3.43	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-1.03%
Market Cap	158.53B	Forward P/E	12.82	EPS next Y	3.67	Insider Trans	-	Shs Float	3.37B	Perf Month	-11.02%
Enterprise Value	169.33B	PEG	1.88	EPS next Q	0.93	Inst Own	9.02%	Short Float	0.84%	Perf Quarter	-16.62%
Income	15.29B	P/S	3.40	EPS this Y	14.21%	Inst Trans	-0.75%	Short Ratio	1.76	Perf Half Y	-31.40%
Sales	46.69B	P/B	7.82	EPS next Y	1.65%	ROA	21.83%	Short Interest	28.24M	Perf YTD	-45.29%
Book/sh	6.02	P/C	30.91	EPS next 5Y	7.28%	ROE	68.30%	52W High	112.52 -58.18%	Perf Year	-54.15%
Cash/sh	1.52	P/FCF	15.85	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	43.08 9.24%	Perf 3Y	-17.03%
Dividend Est.	1.77 (3.75%)	EV/EBITDA	7.35	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	3.72% 3.28%	Perf 5Y	41.49%
Dividend TTM	1.73 (3.67%)	EV/Sales	3.63	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	1.89	Perf 10Y	74.43%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	41.12	Recom	2.16
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	-2.36%	Beta	0.69	Target Price	61.54
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	-12.03%	Rel Volume	1.83	Prev Close	44.97
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-26.58%	Avg Volume	16.05M	Price	47.06
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.07% -3.26%	Trades		Volume	29,326,414	Change	4.65%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120

Show Previous Ratings

Today 02:14PM	These Stocks Are Moving the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohls, Novo Nordisk, Symbotic, and More (Barrons.com)
01:37PM	Here's Why Novo Nordisk Stock Popped Today (Motley Fool)
12:58PM	Novo's Comeback Shot? Weight-Loss Drug Triggers Surprise Rally After Brutal Stock Crash (GuruFocus.com)
12:39PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:10AM	NVO Stock Down as Rybelsus Misses Goals in 2 Alzheimer's Studies (Zacks)
09:47AM	Loading…
09:47AM	Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial (The Wall Street Journal)
09:42AM	Stocks to Watch Tuesday: Alibaba, Alphabet, Novo Nordisk, Kohl's (The Wall Street Journal)
09:08AM	Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better. (Barrons.com)
08:44AM	Novo Nordisk (NVO) is Trending On Reddit - Here's Why (Insider Monkey)
08:07AM	Novo Nordisk's Wegovy Shows Weight Loss-Independent Liver Benefits in MASH Trial Data (Insider Monkey)
08:04AM	Novo Nordisk's weight-loss-drug trial provides rare good news in a rocky year (MarketWatch)
04:22AM	Company News for Nov 25, 2025 (Zacks)
Nov-24-25 06:48PM	Why Novo Nordisk Stock Sank 5.6% Today (Motley Fool) -5.58%
06:42PM	Mizuho's Jared Holz talks Novo Nordisk falling on Alzheimer's trial (CNBC TV)
04:57PM	There's still hope GLP-1 drugs could slow the second-biggest type of dementia (MarketWatch)
04:49PM	Loading…
04:49PM	Biggest Stock Movers Today, Nov. 24: AVGO, NVO, & More (Motley Fool)
04:33PM	Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps (Investor's Business Daily)
04:23PM	Novo Nordisk has a lot of challenges next year and beyond, says Guggenheim's Seamus Fernandez (CNBC TV)
04:17PM	These Stocks Moved the Most Today: Alphabet, Broadcom, Tesla, Nvidia, Novo Nordisk, Oscar Health, Inspire Medical, and More (Barrons.com)
03:05PM	These Stocks Are Moving the Most Today: Alphabet, Broadcom, Tesla, Nvidia, Novo Nordisk, Oscar Health, Inspire Medical, and More (Barrons.com)
02:50PM	Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's (The Wall Street Journal)
02:23PM	Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman (CNBC TV)
12:58PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
12:40PM	Citi's Geoff Meacham: Novo misses on Alzheimer's trial, but 'winners keep winning' in obesity drugs (CNBC TV)
12:30PM	Moderna is the S&P 500's most shorted stock: Here's why (Yahoo Finance Video)
12:15PM	Novo's GLP-1 fails Alzheimer's trial goals, Tegna stock falls (Yahoo Finance Video)
11:46AM	Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock (GuruFocus.com)
11:35AM	Stock Market Today: Dow, Nasdaq Up As This Stock Tests Entry; Health Plays Pop (Live Coverage) (Investor's Business Daily)
11:34AM	Novo Nordisk Stock Falls. Why Its Alzheimer's Trial News Is Hitting Shares. (Barrons.com)
10:59AM	Novo Nordisk Stock Falls Double Digits -- Ozempic Pill Fails Alzheimer's Test (GuruFocus.com)
10:53AM	Loading…
10:53AM	Novo Nordisk shares drop after Alzheimer's trial misses main goal (GuruFocus.com)
10:46AM	Failing Drug Stock Suffers Another Blow on Drug Trial Data (Schaeffer's Research)
10:40AM	Novo Nordisks Alzheimers Trials Were a Long Shot. Their Failure Is Still Hitting the Stock. (Barrons.com)
09:36AM	Stocks to Watch Monday: Alibaba, Tesla, Alphabet, Performance Food (The Wall Street Journal)
09:35AM	Elon Musk hypes Tesla AI chips, Novo stock plunges on drug trial flop (Yahoo Finance Video)
09:32AM	Novo Nordisk Stock Price Falls After Ozempic Fails to Slow Alzheimer's (The Wall Street Journal)
09:22AM	Biogen to gain from Novo Nordisk Alzheimers failure, says Jefferies (Investing.com)
08:30AM	Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand? (Zacks)
08:19AM	Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps (Investor's Business Daily)
08:16AM	Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally (Zacks)
08:06AM	Ukraine peace, robotaxis and pharma: what's moving stocks (Yahoo Finance Video)
07:30AM	Novo Nordisk's oral GLP-1 drug didn't work on Alzheimer's as hoped, and the stock tumbles (MarketWatch)
07:25AM	Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's in Trials. Biogen Jumps. (Barrons.com)
07:13AM	Novo Nordisk slumps, Alphabet gains, and other stocks on the move (MarketWatch)
06:59AM	Novo Nordisk shares sink after Alzheimers drug trial failure (Investing.com)
Nov-23-25 04:30AM	Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? (Motley Fool)
Nov-22-25 06:13PM	2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? (Motley Fool)
01:05PM	3 Top Dividend Stocks to Buy in November (Motley Fool)
Nov-21-25 01:20PM	Ozempic Vision Risk Sparks Payouts: Novo Nordisk's Weight-Loss Empire Faces First Legal Blowback (GuruFocus.com)
01:20PM	Novo Nordisk Patients in Denmark Receive Compensation for Vision Loss Linked to Wegovy and Ozempic (GuruFocus.com)
09:00AM	Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-20-25 11:30AM	VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug (Zacks)
06:45AM	Novo Nordisk Just Saved Denmark's Economy--But for How Long? (GuruFocus.com)
03:40AM	Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly? (Motley Fool)
Nov-19-25 10:14PM	Berenberg Lowers Novo Nordisk (NVO) Price Target to DKK 400, Maintains Buy Rating (Insider Monkey)
05:27PM	HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? (MarketBeat)
01:04PM	Down 45% Year-to-Date, Novo Nordisk Ignites a Price War (MarketBeat)
10:06AM	VNDA Stock Jumps on Upbeat Tradipitant Data Cutting GLP-1 Side Effects (Zacks)
07:11AM	Novo Nordisk (NVO) To Lower US Prices of its Injectable Wegovy Obesity Drug (Insider Monkey)
Nov-18-25 04:21PM	Why biotech and drug stocks are on the mend even though the rest of the market is hurting (MarketWatch)
04:00PM	Why Big Pharma Won't Quit the Diet. Who Will Win the Next Weight Loss Battle? (Motley Fool)
11:42AM	VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know (Zacks)
10:59AM	Pfizer Trading Above 50-Day SMA: Is it a Good Time to Buy the Stock? (Zacks)
12:34AM	Jim Cramer on Novo Nordisk: "You Gotta Let It Come Back a Little" (Insider Monkey)
Nov-17-25 04:44PM	How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration (Investor's Business Daily)
01:04PM	Novo Nordisk Cuts Wegovy and Ozempic Prices to $349 in Direct-to-Consumer Push (GuruFocus.com)
12:01PM	Ozempic is getting cheaper as Novo Nordisk rushes to undercut Eli Lilly (Quartz)
10:24AM	NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock? (Zacks)
09:29AM	Novo cuts obesity drug prices, Alphabet rises, Aramark tumbles (Yahoo Finance Video)
09:08AM	Novo Nordisk, Samsung, XPeng: Stocks Overseas in Focus Today (The Wall Street Journal)
08:33AM	MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026 (Zacks)
07:08AM	Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ (Zacks)
05:25AM	This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? (Motley Fool)
Nov-16-25 12:10PM	Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? (Motley Fool)
Nov-14-25 05:13PM	Retail Investors Really Dont Like Novo Nordisk (NVO) Stock (24/7 Wall St.)
08:53AM	Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance? (Zacks)
08:00AM	Is It Too Late to Buy Novo Nordisk After the Drop? (Motley Fool)
06:15AM	Why Is Everyone Talking About Novo Nordisk Stock? (Motley Fool)
Nov-13-25 03:45PM	AI Frenzy: Everybody Wants NVIDIA's Magical GPUs (Zacks)
12:14PM	Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market (Yahoo Finance)
12:04PM	Pfizer CEO: AI will help with medicine's next big breakthrough (Yahoo Finance Video)
11:58AM	Pfizer plans to enter GLP-1 space by 2028, CEO explains (Yahoo Finance Video)
04:25AM	1 Incredible Reason to Buy LLY's Stock in November (Motley Fool)
Nov-12-25 05:59PM	This biotech is halting its work with Novo Nordisk and laying off more people (MarketWatch)
11:18AM	Novo Nordisk Cuts Wegovy Price in India as Eli Lilly's Mounjaro Leads Market (GuruFocus.com)
08:34AM	Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3? (Zacks)
04:35AM	Why Metsera's Share Price Is Plummeting This Week (Motley Fool)
Nov-11-25 09:55PM	Bernstein Remains Bullish on Novo Nordisk A/S (NVO) (Insider Monkey) +6.99%
03:20PM	Why cutting drug prices is pushing Eli Lilly's stock toward an all-time high (MarketWatch)
02:30PM	Why Metsera is 'in better hands' with Pfizer than Novo Nordisk (Yahoo Finance Video)
11:31AM	Eli Lilly stock soars to new highs, Novo Nordisk lags. Here's why. (Yahoo Finance Video)
11:07AM	3 Buy-And-Forget Dividend Stocks With Snowballing Payouts (24/7 Wall St.)
10:34AM	GLP-1 prices are dropping: Who exactly will benefit? (CNBC TV)
10:08AM	Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
04:25AM	Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? (Motley Fool)
01:02AM	Novo Nordisk Shares Pop After Stepping Back From Metsera Chase (GuruFocus.com)
Nov-10-25 04:59PM	Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion (Investor's Business Daily)
12:58PM	Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. (Barrons.com)
10:45AM	Novo Nordisk Walks Away from $10 Billion Fight--And the Stock Rallies Anyway (GuruFocus.com)
10:36AM	What's Next for Novo Nordisk? (The Wall Street Journal)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience